Wealth Enhancement Advisory Services LLC Purchases 1,466 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Wealth Enhancement Advisory Services LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 40.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,115 shares of the company’s stock after acquiring an additional 1,466 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in HealthEquity were worth $491,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. ABLE Financial Group LLC raised its position in shares of HealthEquity by 8.5% in the 4th quarter. ABLE Financial Group LLC now owns 21,725 shares of the company’s stock valued at $2,085,000 after acquiring an additional 1,709 shares during the period. Forum Financial Management LP bought a new stake in HealthEquity in the fourth quarter valued at approximately $214,000. Public Employees Retirement System of Ohio raised its holdings in HealthEquity by 6.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 97,323 shares of the company’s stock worth $9,338,000 after purchasing an additional 5,569 shares during the period. GTS Securities LLC acquired a new stake in HealthEquity in the fourth quarter worth $239,000. Finally, AlphaQ Advisors LLC bought a new position in shares of HealthEquity during the fourth quarter worth $313,000. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jon Kessler sold 134,183 shares of the business’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director now directly owns 253,510 shares of the company’s stock, valued at approximately $28,413,400.80. The trade was a 34.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 304,581 shares of company stock valued at $33,664,018 over the last 90 days. Company insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

NASDAQ:HQY opened at $103.99 on Friday. The firm has a market capitalization of $8.99 billion, a price-to-earnings ratio of 95.40, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a fifty day moving average of $93.40 and a 200 day moving average of $97.88. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analysts’ expectations of $322.25 million. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm earned $0.80 earnings per share. On average, research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HQY shares. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. Royal Bank of Canada lifted their target price on HealthEquity from $112.00 to $117.00 and gave the company an “outperform” rating in a research report on Wednesday, June 4th. JMP Securities upped their price target on HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a research report on Wednesday, June 4th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, Wells Fargo & Company lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $118.09.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.